The major goal of this project is to enhance the ReDLat Consortium’s capacity to identify potential candidates for clinical trials focusing on progranulin haploinsufficiency. It aims to build research capabilities within selected Latin American centers, establishing them as viable future locations for clinical trials.
PI: Claudia Duran-Aniotz
Support:The Bluefield Project to Cure Frontotemporal Dementia
